PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10576437-2	1999	Stobadine administered locally into the colon was found to reduce the extent of colonic mucosal injury, abolish the increase in myeloperoxidase activity, attenuate the enhanced vascular permeability, and prevent the depletion of reduced glutathione.	dicarbine	0-9	myeloperoxidase	Homo sapiens	128-143	
16871535-4	2007	On the other hand, myeloperoxidase (MPO) liberation was decreased by stobadine only in the concentration of 100 micromol/L.	dicarbine	69-78	myeloperoxidase	Homo sapiens	19-34	
16871535-4	2007	On the other hand, myeloperoxidase (MPO) liberation was decreased by stobadine only in the concentration of 100 micromol/L.	dicarbine	69-78	myeloperoxidase	Homo sapiens	36-39	
16871535-5	2007	The results showed stobadine to act as a potent inhibitor/scavenger of extracellularly produced ROM in human PMNL and indicated interference of stobadine with ROM as well as with signalling events resulting in NADPH-oxidase activation and MPO liberation.	dicarbine	19-28	myeloperoxidase	Homo sapiens	239-242	
16871535-5	2007	The results showed stobadine to act as a potent inhibitor/scavenger of extracellularly produced ROM in human PMNL and indicated interference of stobadine with ROM as well as with signalling events resulting in NADPH-oxidase activation and MPO liberation.	dicarbine	144-153	myeloperoxidase	Homo sapiens	239-242